Building Partnerships with Shenandoah Biotechnology

Shenandoah is officially joining forces with ImmunoReagents.

As of May 1, 2015, Shenandoah Biotechnology will be transferring our current lines of monoclonal and polycolonal antibodies (with the exception of our Anti-IL-35 monoclonal antibodies) to ImmunoReagents.  Shenandoah is discontinuing our antibody line of products because we want to be able to solely focus on what we excel at… RECOMBINANT PROTEINS!  By transferring our antibody product line to ImmunoReagents Inc, we can focus exclusively on bringing new high quality recombinant proteins to the research market while expanding ImmunoReagents offerings of high quality antibodies.

Shenandoah plans to partner with ImmunoReagents to expand our product offerings for the future.  By providing Immuoreagents high quality proteins to use as immunogens, Shenandoah and ImmunoReagents will develop superior antibodies and super sensitive ELISA kits.

Shenandoah is excited to be working with ImmunoReagents because we share common goals and philosophies.  Both companies are small, woman owned biotechnology companies, that believe in customer focused products and services.  Joining forces allows each company to focus on the manufacturing processes that we excel at, while also increasing our footprint in the market.  Together we hope that this partnership will benefit Shenandoah’s and ImmunoReagent’s customers by providing all of the tools a scientist needs to paint a complete and accurate scientific picture.

About ImmunoReagents, Inc.

ImmunoReagents is a leading global manufacturer of quality antibodies and reagents used in research and in vitro diagnostics. Product offerings include a wide range of immunochemistry reagents such as purified immunoglobulins, primary antibodies and secondary antibodies covering a broad spectrum of immunoglobulin from various species. ImmunoReagents also provides custom manufacturing to meet specific customer requirements while adhering to cGMP guidelines and ISO quality systems requirements. The Company is located in Raleigh, North Carolina.

For more information, please see www.immunoreagents.com